127 related articles for article (PubMed ID: 18434772)
1. Parafibromin as a tool for the diagnosis of parathyroid tumors.
Marcocci C; Cetani F
Adv Anat Pathol; 2008 May; 15(3):179; author reply 179-80. PubMed ID: 18434772
[No Abstract] [Full Text] [Related]
2. Parafibromin immunohistochemical staining to differentiate parathyroid carcinoma from parathyroid adenoma.
Kim HK; Oh YL; Kim SH; Lee DY; Kang HC; Lee JI; Jang HW; Hur KY; Kim JH; Min YK; Chung JH; Kim SW
Head Neck; 2012 Feb; 34(2):201-6. PubMed ID: 21717519
[TBL] [Abstract][Full Text] [Related]
3. Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression.
Woodard GE; Lin L; Zhang JH; Agarwal SK; Marx SJ; Simonds WF
Oncogene; 2005 Feb; 24(7):1272-6. PubMed ID: 15580289
[TBL] [Abstract][Full Text] [Related]
4. Aspiration cytology of parathyroid adenoma: radioimmunoassay of parathormone in aspirate as a helpful diagnostic tool.
Ryşka A; Kerekes Z; Cáp J
Acta Cytol; 1998; 42(3):826-7. PubMed ID: 9622722
[No Abstract] [Full Text] [Related]
5. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
Gill AJ; Clarkson A; Gimm O; Keil J; Dralle H; Howell VM; Marsh DJ
Am J Surg Pathol; 2006 Sep; 30(9):1140-9. PubMed ID: 16931959
[TBL] [Abstract][Full Text] [Related]
6. Electron probe analysis for iodine in human thyroid and parathyroid glands, normal and neoplastic.
Banfield WG; Grimley PM; Hammond WG; Taylor CM; DeFlorio B; Tousimis AJ
J Natl Cancer Inst; 1971 Feb; 46(2):269-73. PubMed ID: 4940240
[No Abstract] [Full Text] [Related]
7. Parafibromin expression, single-gland involvement, and limited parathyroidectomy in familial isolated hyperparathyroidism.
Iacobone M; Barzon L; Porzionato A; Masi G; Macchi V; Marino F; Viel G; Favia G
Surgery; 2007 Dec; 142(6):984-91; discussion 984-91. PubMed ID: 18063086
[TBL] [Abstract][Full Text] [Related]
8. Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification.
Juhlin CC; Villablanca A; Sandelin K; Haglund F; Nordenström J; Forsberg L; Bränström R; Obara T; Arnold A; Larsson C; Höög A
Endocr Relat Cancer; 2007 Jun; 14(2):501-12. PubMed ID: 17639063
[TBL] [Abstract][Full Text] [Related]
9. Metastatic parathyroid carcinoma initially misdiagnosed as parathyroid adenoma: the role of parafibromin in increasing diagnostic accuracy.
Lim S; Elston MS; Gill AJ; Marsh DJ; Conaglen JV
Intern Med J; 2011 Sep; 41(9):695-9. PubMed ID: 21899683
[TBL] [Abstract][Full Text] [Related]
10. Loss of parafibromin expression in a subset of parathyroid adenomas.
Juhlin C; Larsson C; Yakoleva T; Leibiger I; Leibiger B; Alimov A; Weber G; Höög A; Villablanca A
Endocr Relat Cancer; 2006 Jun; 13(2):509-23. PubMed ID: 16728578
[TBL] [Abstract][Full Text] [Related]
11. Defining a molecular phenotype for benign and malignant parathyroid tumors.
Fernandez-Ranvier GG; Khanafshar E; Tacha D; Wong M; Kebebew E; Duh QY; Clark OH
Cancer; 2009 Jan; 115(2):334-44. PubMed ID: 19107770
[TBL] [Abstract][Full Text] [Related]
12. Galectin-3 and Ki-67 expression in multiglandular parathyroid lesions.
Saggiorato E; Bergero N; Volante M; Bacillo E; Rosas R; Gasparri G; Orlandi F; Papotti M
Am J Clin Pathol; 2006 Jul; 126(1):59-66. PubMed ID: 16753595
[TBL] [Abstract][Full Text] [Related]
13. Molecular Characteristics of Large Parathyroid Adenomas.
Agarwal A; Pradhan R; Kumari N; Krishnani N; Shukla P; Gupta SK; Chand G; Mishra A; Agarwal G; Verma AK; Mishra SK
World J Surg; 2016 Mar; 40(3):607-14. PubMed ID: 26669787
[TBL] [Abstract][Full Text] [Related]
14. Letter 2: Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma (Br J Surg 2007; 94: 566-570).
Meyer-Rochow GY; Alvarado R; Sywak MS; Sidhu SB; Delbridge LW; Gill AJ
Br J Surg; 2007 Aug; 94(8):1043; author reply 1043-4. PubMed ID: 17636522
[No Abstract] [Full Text] [Related]
15. Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma?
Cetani F; Ambrogini E; Viacava P; Pardi E; Fanelli G; Naccarato AG; Borsari S; Lemmi M; Berti P; Miccoli P; Pinchera A; Marcocci C
Eur J Endocrinol; 2007 May; 156(5):547-54. PubMed ID: 17468190
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hyperplasia versus adenoma--clinical or histologic diagnosis.
Sicard GA
Surgery; 1981 Jul; 90(1):125-6. PubMed ID: 7245047
[No Abstract] [Full Text] [Related]
17. [Detection of parathyroid tumor and hyperplasia with real time sonography].
Mäkäräinen H; Suramo I; Kairaluoma MI
Duodecim; 1983; 99(12):766-72. PubMed ID: 6884246
[No Abstract] [Full Text] [Related]
18. Diagnostic and prognostic implications of parafibromin immunohistochemistry in parathyroid carcinomaT.
Pyo JS; Cho WJ
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30926677
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of CASR expression and global loss of parafibromin staining are strong negative determinants of prognosis in parathyroid carcinoma.
Witteveen JE; Hamdy NA; Dekkers OM; Kievit J; van Wezel T; Teh BT; Romijn JA; Morreau H
Mod Pathol; 2011 May; 24(5):688-97. PubMed ID: 21240254
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid adenoma.
Garg P; Daga SR
Indian Pediatr; 2006 Aug; 43(8):747-8. PubMed ID: 16951447
[No Abstract] [Full Text] [Related]
[Next] [New Search]
